Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
HDA Statement on Maryland Legislation Designed to Clarify Role of Critical Pharmacy Partners
The Healthcare Distribution Alliance (HDA) issued the following statement today from HDA Senior Vice President of State Government Affairs and Alliance Development Matt DiLoreto, upon introduction of SB 823 and HB 973 by the Maryland Legislature.
Healthcare Distributors Are Making a Difference in Local Communities
Long before the COVID-19 pandemic, HDA healthcare distributors recognized the vital role that philanthropy plays in building healthier communities — and the industry’s responsibility in leading these efforts.
Logistics Will Help Win the Battle Against COVID-19
Across the country, brave, frontline healthcare professionals are working around the clock as our nation grapples with the COVID-19 pandemic. These workers — the true heroes of the pandemic — are treating patients, maintaining vital healthcare operations and serving as emergency responders.
Spotlighting HerStory: Discussions With Women in Distribution
As March comes to a close, HDA is rounding out Women’s History Month celebrations by sharing perspectives from some of the incredible women making a difference within the distribution sector and the larger healthcare ecosystem. Interviews were conducted in conjunction with the recent Distribution Management Conference and other forums in support of HDA’s Faces of the Supply Chain video series, a new initiative of the Health Delivered campaign.
Leveraging Public and Private Sector Collaboration to Respond to COVID-19
While it has only been a few months since the first American was diagnosed with COVID-19, the scope of the pandemic is one which we have never experienced before. Throughout, it has become abundantly clear that our nation’s ability to effectively respond to this once-in-a-lifetime crisis depends on the public and private sectors joining forces, maintaining constant coordination, and working together to identify operational and regulatory barriers impeding access to medicines and medical supplies.